CD19 antibody (PE)

Catalog No. ABIN2704188

Product Details anti-CD19 Antibody (PE)

Target: CD19 (CD19 Molecule (CD19))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD19 antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Characteristics: The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.

Purification: Purified

Purity: >95 %

Grade: GMP Grade

Immunogen: Human CCL (chronic lymphocytic leukemia) cells

Clone: 4G7

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 25 μg/mL

Buffer: PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Target Details for CD19

Target: CD19 (CD19 Molecule (CD19))

Alternative Name: CD19 (CD19 Products)

Synonyms: B4 antibody, CVID3 antibody, AW495831 antibody, CD19 antibody, CD19 molecule antibody, CD19 antigen antibody, CD19 antibody, Cd19 antibody

Background: The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.

NCBI Accession: NM_001770

UniProt: P15391

Pathways: Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway